uniQure N.V

Financials

Total assets 340.39 M809.18 M704.96 M831.69 M556.54 M824.91 M Total liabilities 96.49 M213.4 M228.96 M624.02 M563.29 M626.01 M Total equity 243.91 M595.78 M476.01 M207.67 M-6.75 M198.9 M Total liabilities & shareholders' equities 340.39 M809.18 M704.96 M831.69 M556.54 M824.91 M Total debt 35.62 M100.96 M102.79 M101.75 M51.32 M49.7 M Net debt -209.31 M-455.29 M-250.05 M-516.28 M-316.36 M-573.15 M

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

QURE

Financials

uniQure N.V

Notícias

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

Mizuho eleva rating da uniQure após mudança na liderança do FDA

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

Chardan eleva preço-alvo da uniQure após mudança na liderança do FDA

Chardan raises uniQure stock price target on FDA leadership change

Tesla and Facebook among market cap stock movers on Monday

Biotech Stocks Pop After CBER Chief Exit - Moderna (NASDAQ:MRNA)